Search PillsburyLaw.com
  • All
  • Lawyers
  • Capabilities
  • Insights

Service

Digital Health

See Associated Professionals

Areas of Focus

Digital health encompasses a wide range of industries, technologies and products, all aimed toward a simple but profound goal—the radical improvement of health care outcomes for everyone.

Pillsbury’s Digital Health lawyers advise on the full spectrum of legal, business and regulatory issues and provide solution-oriented guidance on all facets of this swiftly evolving, transformative sector. We have in-depth experience advising digital health businesses in AI, telehealth and telemedicine, mobile health (mHealth), digital therapeutics, apps, wearable technology, big data, blockchain and personalized medicine.

Pillsbury’s multidisciplinary group, which draws on the firm’s established technology, life sciences and health care industry practices, advises digital health clients in all stages of the business lifecycle, including company formation, venture capital financings, corporate governance, IPOs, mergers & acquisitions, tech transactions, strategic collaborations and licensing agreements, global sourcing, patents, HIPAA and other data privacy laws, and litigation and enforcement matters.

From helping mobile health, telehealth and wearable tech companies secure game-changing intellectual property to enabling clients to leverage and protect the data powering revolutionary advances in personalized medicine, our digital health attorneys have extensive experience working with all the components of this emerging sector.

Recent Work Highlights

  • Represented Rockley Photonics in its $1.2B business combination with SC Health.
  • Represented wearable biosensor developer Biolinq in its $100M Series B financing. 
  • Represented leading online health staffing marketplace Nomad Health in its $105M financing round.

View More

  • Venture Financings
    • Represented AlleyCorp in connection with digital addiction recovery business Affect Therapeutic's $6M seed funding round. 
    • Represented Babson Diagnostics, Inc., a medical technology company dedicated to bringing diagnostic blood testing to the retail pharmacy counter, in its $31M Series B financing. 
    • Represented digital health development platform Capable Health and AlleyCorp in connection with Capable's series seed-1 funding.
    • Represented Cartessa Aesthetics, LLC, a distributor of aesthetic medical equipment to cosmetic physicians and medical spas, in its $35M funding round. 
    • Represented "smart cradle" developer Cradlewise in its $7M seed funding round. 
    • Represented Premji Invest/Hasham Trader in connection with senior-focused health care company Devoted Health on its $1.15B Series D financing. 
    • Represented maternity-focused digital health provider Diana Health, Inc. in its $11M Series A financing. 
    • Represented AI-driven therapeutics company Envisagenics, Inc. in its Series A financing. 
    • Represented AlleyCorp in their investment in Exavir Therapeutics, a preclinical stage biotech company focused on eliminating HIV and other viral infections.
    • Represented Premji Invest/Hasham Trader in connection with virtual first health care company Firefly Health's 40M Series B financing. 
    • Represented minority-focused digital health company HUED in its $1.6M seed funding round. 
    • Represented AI-focused preliminary diagnostic and patient triage solutions provider Infermedica in its $30M Series B financing.
    • Represented health care member acquisition, retention, and engagement platform Insightin Health, Inc. in its $12M Series A financing. 
    • Represented AlleyCorp in connection with complex care delivery platform Memora Health's  $10.5M Series A financing and $40M Series B financing.
    • Represented clinical decision support solution Nightingale and AlleyCorp in connection with Nightingale's $1M seed funding round.
    • Represented primary care provdier support platform Pearl Health and AlleyCorp in connection with Pearl's $18M Series A financing. 
    • Represented medical device company Raydiant Oximetry in its $5M Series A-2 financing. 
    • Represented Tele911 Inc.,  a technology company that integrates with EMS Provider Agencies to care for stable patients, in its undisclosed seed funding round. 
    • Represented virtual musculoskeletal care provider Vori Health, Inc. in its $50M+ Series A extension. 
    • Represented managed-care contracting engine Yuvo Health in its $7.3M seed funding round. 
  • Mergers & Acquisitions
    • Represented ReDesign Health in its acquisition of substantially all of the assets of Together Senior Health.
    • Represented Uqora in its sale to Pharmavite.
    • Represented IQVIA in acquisition of 40% minority share of Q2 Solutions resulting in 100% ownership by IQVIA. 
    • Represented Yamada Bee Company, Inc. in its $2M acquisition of Series A Preferred Units in AHNP, LLC. 
    • Represented IQVIA in acquisition of Advance Health Media.
    • Represented Truven Health Analytics Inc., a provider of healthcare data and analytics solutions and services, regarding the government contracts and health care regulations aspects of its $2.6 billion sale to IBM. 
    • Represented IMS Health in its acquisition of all assets of ViS Research, Inc., an online feasibility platform focused on optimizing clinical trial planning.
    • Represented IMS Health in its acquisition, via stock purchase, of Grace Data Corporation (d/b/a Healthcare Data Solutions), a provider of healthcare data, physician validation programs, data processing, compliance solutions and web services.
    • Represented IMS Health in its acquisition of Appature, a leading Software-as-a-Service (SaaS) company based in Seattle, to further expand its commercial services capabilities for life sciences and healthcare organizations. 
    • Represented IMS Health in its acquisition of 360 Vantage, a leading developer and provider of CRM, marketing and data management solutions, for approximately $30 million.
    • Represented Quantros, Inc., a privately owned health care software company, in its acquisition by Francisco Partners LP.
    • Represented Systems Made Simple, Inc., a leading provider of health information technology solutions to the U.S. federal government, in its acquisition by Lockheed Martin.
      Represented IMS Health in its acquisition of Global Channel Marketing Solutions, LLC for $1.74 million.
    • Represented IMS Health in its acquisition of the assets of 360 Vantage Software Technology Private Limited, a developer and provider of CRM, marketing and data management solutions and a wholly affiliate 360 Vantage LLC, for approximately $1 million.
    • Represented Rockley Photonics in its $1.2B business combination with SC Health.

Practice Area Highlights

  • Ranked by Refinitiv among the Top 3 most active law firms for venture capital financings globally in 2021.
  • Ranked by Pitchbook among the Top 10 most active law firms advising life sciences & biotech companies of venture capital financings.
  • Recognized by Chambers USA as a national leader for startups and emerging growth work. 

Related Insights

View More
View All